Skip to content

Ichor Holdings ICHR Capital investments accrued but not yet paid

Capital investments accrued but not yet paid at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$256.1M+4.7%
Gross profit$32.3M+13.1%
Operating income$2.1M+278%
Net income-$2.5M+45.8%
EPS (diluted)-$0.07+46.2%

Balance sheet

See full
Cash & equivalents$89.1M-18.5%
Total debt$158.7M-6.6%
Total equity$668.0M-4.6%
Total assets$972.5M-3.4%

Cash flow

See full
Operating cash flow-$2.9M-115%
CapEx$7.1M-61.8%
Free cash flow-$10.0M-2,113%

Valuation

See full
Market cap$3.21B+110%

Profitability

See full
Gross margin9.5%-2.7pp
Operating margin-3.8%-4.6pp
Net margin-5.3%-11.3pp
FCF margin6.4%+2.2pp

Returns & leverage

See full
Return on equity-7.4%-13.8pp
Debt / equity0.2×0.0×
Current ratio2.8×-0.3×

Where this comes from

Reported directly by Ichor Holdings in its filing.

Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.

The official record: Ichor Holdings’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ichor Holdings's capital investments accrued but not yet paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ichor Holdings's capital investments accrued but not yet paid?
Ichor Holdings (ICHR) reported capital investments accrued but not yet paid of $412K in Q1 2026.
How has Ichor Holdings's capital investments accrued but not yet paid changed year-over-year?
Ichor Holdings's capital investments accrued but not yet paid decreased by 71.9% year-over-year, from $1.47M to $412K.